When was Immunitas Therapeutics founded?
Immunitas Therapeutics was founded in 2019.
Where are Immunitas Therapeutics headquarters?
Immunitas Therapeutics headquarters are in 21 Hickory Dr, Waltham, Massachusetts 02451, US.
How many employees does Immunitas Therapeutics have?
Immunitas Therapeutics has 31 employees.
What sector does Immunitas Therapeutics operate in?
Immunitas Therapeutics is in Biotechnology Research sector.
What does Immunitas Therapeutics Do ?
Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering. IMT-009, a first-in-class T & NK cell modulator targeting CD161, is being developed for the treatment of solid tumors and hematological malignancies. The company was founded with leading scientists from Dana Farber, MGH, the Broad, and MIT. In 2019, Immunitas raised a $39M Series A from a strong syndicate of investors including the Longwood Fund, Hillhouse, NVF, Leaps by Bayer, and M Ventures.
What does Immunitas Therapeutics specialize into ?
We are not able to find any specialities related to Immunitas Therapeutics at the moment.
Who is the CEO of Immunitas Therapeutics ?
We do not have the information about the CEO of Immunitas Therapeutics. Our systems are trying to find it, we will update it as soon as we have it.
Try Mr. E's contact finder tool and fetch direct mobile numbers of decision-makers of all companies globally. Grow your sales now.
Free Trial with 5 contacts. No Credit Card Required. One-click Signup.